Tempest Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tempest Therapeutics's estimated annual revenue is currently $5.1M per year.
- Tempest Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Tempest Therapeutics has 33 Employees.
- Tempest Therapeutics grew their employee count by 3% last year.
Tempest Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP, Regulatory and Quality | Reveal Email/Phone |
2 | VP, Chemistry | Reveal Email/Phone |
3 | VP, Strategy and Finance | Reveal Email/Phone |
4 | VP, Clinical Operations | Reveal Email/Phone |
5 | SVP, Research and Development | Reveal Email/Phone |
6 | SVP, Head Project Team Leadership, Project Management and Portfolio Management | Reveal Email/Phone |
7 | Executive Director, Discovery Research | Reveal Email/Phone |
8 | Executive Director, Translational Science | Reveal Email/Phone |
9 | EVP and Chief Medical Officer | Reveal Email/Phone |
10 | Executive Assistant Office Manager | Reveal Email/Phone |
Tempest Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Tempest Therapeutics?
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. Tempest has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct immune response pathways relevant to mounting an effective anti-tumor response. The molecules were developed by Inception Sciences, a Versant Ventures affiliated drug discovery engine. Tempest has assembled a highly experienced team of small molecule and immuno-oncology drug developers to advance these programs to the clinic across diverse cancers representing significant unmet medical need. Tempest is backed by a syndicate of leading US and China based venture capital firms.
keywords:N/A
N/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tempest Therapeutics News
Tempest Therapeutics Inc, a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's...
Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting. Tempest Therapeutics. April 8, 2022 ·7 min read.
Tempest Therapeutics is a clinical-stage oncology company advancing small molecules that combine both tumor-targeted and immune-mediated...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.1M | 33 | -44% | $71.7M |
#2 | $3.6M | 33 | -6% | $16M |
#3 | $3.7M | 33 | -15% | $2M |
#4 | $3.8M | 33 | -40% | N/A |
#5 | $3.8M | 33 | 27% | N/A |